BackAbattis Bioceuticals Overview

Abattis Bioceuticals Cost of Revenue

Cost of Revenue analysis for ATTBF.

Quarterly Cost of Revenue

$64134.00

As of Sep 30, 2019

Annual Cost of Revenue (TTM)

$115540.00
6000.32% YoY

Trailing 12 months ending Sep 30, 2019

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)